Research Bibliography

Systematic review confirmed thymosin alpha-1 as safe and efficacious for hepatitis B treatment and immune reconstitution.

Population: Pooled clinical trial data across multiple countries

Cited in: Thymosin Alpha-1

Meta-analysis of STEP trials confirmed consistent 10-17% weight loss across diverse populations with semaglutide 2.4mg.

Population: Pooled analysis of STEP 1-5 trials (n>5,000)

Cited in: Semaglutide

Glucagon receptor agonism in Mazdutide directly drove massive clearance of hepatic triglycerides beyond what GLP-1 alone achieves.

Population: Diet-induced obese mice with hepatic steatosis

Cited in: Mazdutide

Retatrutide caused up to 24.2% weight loss at 48 weeks at the highest dose (12 mg) in adults with obesity.

Population: Adults with obesity (BMI ≥30) without diabetes (n=338)

Cited in: Retatrutide

Demonstrated robust reductions in HbA1c and body weight with an acceptable safety profile in T2D patients.

Population: Adults with T2D inadequately controlled on metformin (n=281)

Cited in: Retatrutide

Tirzepatide at 15mg produced 22.5% mean body weight reduction over 72 weeks, exceeding all prior GLP-1 results.

Population: Adults with obesity without diabetes (n=2,539)

Cited in: Tirzepatide

The SURMOUNT program demonstrated dose-dependent weight loss of 15-22.5% across multiple dose levels of tirzepatide.

Population: Adults with BMI ≥30 or ≥27 with comorbidities (n=2,539)

Cited in: Tirzepatide

Amylin analogues like cagrilintide represent a distinct and highly effective alternative pathway for combating obesity independent of GLP-1 receptor agonism.

Population: Review of Phase I/II cagrilintide clinical data

Cited in: Cagrilintide

The dual agonist significantly lowered HbA1c and body weight while drastically reducing liver fat content compared to placebo.

Population: Chinese adults with T2D inadequately controlled on metformin (n=150)

Cited in: Mazdutide

Showed that the triple agonism drives superior weight loss and energy expenditure increases compared to dual or single agonists in murine models.

Population: Diet-induced obese mice and non-human primates

Cited in: Retatrutide

Semaglutide 2.4mg weekly produced 14.9% mean body weight reduction versus 2.4% with placebo over 68 weeks.

Population: Adults with BMI ≥30 or ≥27 with comorbidities (n=1,961)

Cited in: Semaglutide

Thymosin alpha-1 enhanced T-cell differentiation, dendritic cell activation, and natural killer cell cytotoxicity across multiple disease states.

Population: Clinical studies in hepatitis, cancer, and immunodeficiency patients

Cited in: Thymosin Alpha-1

Evaluates FOXO4-DRI alongside other senolytics for their ability to delay, prevent, or alleviate age-related conditions by removing SASP-secreting cells.

Population: Comprehensive review of senolytic compounds in animal models

Cited in: FOXO4-DRI

Treatment with MOTS-c significantly improved physical capacity and lifespan in late-life mice.

Population: Aged C57BL/6N mice (16 months old)

Cited in: MOTS-C

Cagrilintide induced significant, dose-dependent weight loss compared to placebo, establishing its efficacy as a standalone weight management agent.

Population: Adults with BMI ≥30 or ≥27 with comorbidities (n=706)

Cited in: Cagrilintide

The combination of cagrilintide and semaglutide produced significantly greater weight loss than either peptide administered alone, proving their synergistic mechanism.

Population: Adults with obesity without diabetes (n=92)

Cited in: Cagrilintide

Mazdutide generated dose-dependent weight loss up to an average of 18.6% at the highest 9mg dose over 24 weeks.

Population: Chinese adults with BMI ≥28 or ≥24 with comorbidities (n=187)

Cited in: Mazdutide

Bremelanotide significantly increased sexual desire and reduced distress in premenopausal women with hypoactive sexual desire disorder.

Population: Premenopausal women with HSDD (n=1,247)

Cited in: PT-141

NNMT is established as a critical metabolic checkpoint, directly linking its overexpression to obesity and type 2 diabetes.

Population: Review of preclinical NNMT inhibitor studies

Cited in: 5-Amino-1MQ

Detailed the mechanistic pathways by which Humanin prevents apoptosis and mitigates age-related diseases.

Population: Review of preclinical humanin studies across disease models

Cited in: Humanin

Summarizes how MOTS-c translocates to the nucleus to regulate metabolic gene expression during cellular stress.

Population: Review of MDP biology across preclinical models

Cited in: MOTS-C

SNARE-complex mimicking peptides intercept acetylcholine release mechanisms, offering a viable, lower-toxicity alternative to injectable botulinum toxins.

Population: Review comparing injectable neurotoxins to topical peptide alternatives

Cited in: SNAP-8

Pulsatile infusion effectively restores spermatogenesis and testosterone levels in hypogonadal men.

Population: Males with hypogonadotropic hypogonadism treated with pulsatile GnRH pumps

Cited in: Gonadorelin

BPC-157 demonstrated comparable or superior angiogenic effects to standard growth factors like VEGF and bFGF in multiple wound models.

Population: Sprague-Dawley rats with surgically induced wounds

Cited in: BPC-157 , Peptide Cycling: When to Take Breaks

5-Amino-1MQ reduced body weight and white adipose tissue mass by 30% in diet-induced obese mice without affecting food intake.

Population: Diet-induced obese C57BL/6J mice

Cited in: 5-Amino-1MQ

Inhibiting NNMT with 5-Amino-1MQ restored NAD+ levels and improved muscle regeneration in aged mice.

Population: Aged C57BL/6J mice with sarcopenia

Cited in: 5-Amino-1MQ

Comprehensive review establishing BPC-157 as a stable gastric pentadecapeptide with broad cytoprotective and healing properties across multiple organ systems.

Population: Preclinical animal models and in-vitro studies

Cited in: BPC-157

Co-administration of Selank with diazepam enhanced anxiolytic effects while reducing the sedative properties of the benzodiazepine.

Population: Male Wistar rats

Cited in: Selank

FOXO4-DRI selectively induced apoptosis in senescent cells and restored fitness, fur density, and renal function in aging mice.

Population: Fast-aging (XpdTTD/TTD) and naturally aged mice

Cited in: FOXO4-DRI

Outlines the therapeutic mechanism of disrupting the FOXO4-p53 axis to clear senescent cells without harming healthy tissue.

Population: Review of preclinical senolytic studies

Cited in: FOXO4-DRI

Administration of kisspeptin acutely enhanced brain activity in limbic regions associated with sexual arousal and reward processing.

Population: Healthy heterosexual men (n=29)

Cited in: Kisspeptin-10

Topically applied peptides, specifically neurotransmitter inhibitors like SNAP-8, show significant clinical efficacy in reducing the depth of facial wrinkles.

Population: Review of clinical trials with cosmetic peptide formulations

Cited in: SNAP-8

Demonstrated therapeutic potential of thymosin beta-4 across cardiac repair, dermal wound healing, and corneal regeneration.

Population: Multiple preclinical and early clinical models

Cited in: TB-500

GHK-Cu activates over 4,000 human genes involved in tissue remodeling, antioxidant defense, and stem cell activity.

Population: In-vitro human cell cultures and gene expression databases

Cited in: GHK-Cu

MOTS-c administration in mice prevented high-fat diet-induced obesity and reversed age-dependent insulin resistance.

Population: C57BL/6J mice on high-fat diet

Cited in: MOTS-C

Dihexa drove new synapse formation and dendritic spine growth via direct activation of the HGF/c-Met signaling axis.

Population: Hippocampal neuronal cultures and aged rat models

Cited in: Dihexa

A 28-day protocol of ARA-290 improved HbA1c levels and reduced neuropathic pain symptoms in diabetic patients.

Population: Type 2 diabetes patients with neuropathy (n=48)

Cited in: ARA-290

The peptide blocked macrophage activation and provided long-term relief from neuropathic pain in peripheral nerve injury models.

Population: Rats with chronic constriction injury

Cited in: ARA-290

Continuous exposure to Kisspeptin-10 resulted in a rapid decline in testosterone and LH, proving that pulsatile dosing is absolutely required for HPTA stimulation.

Population: Healthy adult males (n=8)

Cited in: Kisspeptin-10

Elevating Klotho expression improved learning and spatial memory while increasing synaptic plasticity in the hippocampus.

Population: Young and aged transgenic mice with Klotho overexpression

Cited in: Klotho

SS-31 specifically binds to cardiolipin to protect mitochondrial structure and ATP production under extreme cellular stress.

Population: Review of preclinical ischemia-reperfusion and aging models

Cited in: SS-31

Systemic oxytocin administration rapidly restores muscle regeneration in old mice by activating muscle stem cells.

Population: Young (3-month) and aged (18-24 month) C57BL/6 mice

Cited in: Oxytocin

ARA-290 administration significantly reduced neuropathic pain and improved quality of life in sarcoidosis patients.

Population: Sarcoidosis patients with small fiber neuropathy (n=22)

Cited in: ARA-290

Detailed the extensive biological roles of carnosine including pH buffering, heavy metal chelation, and antioxidant activity.

Population: Review of human and animal carnosine studies

Cited in: Carnosine

Elongated octapeptides demonstrate approximately 30% greater efficacy in SNARE complex destabilization compared to their hexapeptide predecessors.

Population: Reconstituted SNARE complex preparations

Cited in: SNAP-8

An 8-day protocol of SS-31 in aged mice rapidly reversed age-related declines in mitochondrial ATP production and improved muscle endurance.

Population: Aged C57BL/6 mice (26-28 months old)

Cited in: SS-31

Thymosin beta-4 promotes wound healing through upregulation of actin, angiogenesis, and anti-inflammatory activity.

Population: Preclinical models and clinical wound studies

Cited in: TB-500

26-week tesamorelin treatment significantly reduced VAT and improved triglyceride levels without adverse glucose effects.

Population: HIV-infected adults with lipodystrophy (n=806)

Cited in: Tesamorelin

Dihexa restored cognitive function in aged and scopolamine-impaired rats through HGF/c-Met-mediated synaptogenesis.

Population: Aged Fischer 344 rats and scopolamine-impaired young rats

Cited in: Dihexa

The KPV tripeptide maintains the full anti-inflammatory capacity of the parent alpha-MSH hormone without triggering pigment-producing pathways.

Population: Review of in-vitro and animal inflammation models

Cited in: KPV

Pre-treatment with SS-31 significantly reduced infarct size and protected cardiac tissue during simulated heart attacks.

Population: Rabbit and rat cardiac ischemia-reperfusion models

Cited in: SS-31

A single intravenous injection of Kisspeptin-10 powerfully stimulated LH secretion and temporarily increased LH pulse frequency in healthy male subjects.

Population: Healthy adult males (n=6)

Cited in: Kisspeptin-10

Pulsatile administration stimulates gonadotropin release while continuous delivery induces receptor downregulation.

Population: Review of GnRH clinical applications across reproductive medicine

Cited in: Gonadorelin

Detailed mapping of how oxytocin acts as a central neurotransmitter to regulate stress and social behavior.

Population: Review of human and primate neuropeptide research

Cited in: Oxytocin

BPC-157 significantly accelerated tendon-to-bone healing with improved biomechanical properties at the repair site.

Population: Rat Achilles tendon detachment model

Cited in: BPC-157

Tesamorelin reduced trunk fat by 15% and visceral adipose tissue significantly in HIV-positive patients with lipodystrophy.

Population: HIV-positive adults with abdominal lipohypertrophy (n=412)

Cited in: Tesamorelin

Follistatin overexpression produced dramatic increases in skeletal muscle mass through myostatin and activin inhibition.

Population: Transgenic mice with follistatin overexpression

Cited in: Follistatin

Demonstrated that elevating muscle carnosine significantly improves high-intensity exercise performance.

Population: Trained and untrained human athletes

Cited in: Carnosine

Follistatin is the most potent natural myostatin inhibitor, capable of driving muscle growth even in myostatin-knockout models.

Population: Preclinical animal models and in-vitro studies

Cited in: Follistatin

Highlighted carnosine's ability to inhibit protein glycation and delay cellular senescence in human fibroblasts.

Population: In-vitro fibroblasts and dietary intervention studies

Cited in: Carnosine

Demonstrated that central administration of Humanin significantly improves peripheral insulin sensitivity.

Population: Male Sprague-Dawley rats with intracerebroventricular administration

Cited in: Humanin

Soluble Klotho acts as an endocrine factor that suppresses oxidative stress and regulates multiple aging-associated signaling pathways.

Population: Review of Klotho biology across mammalian models

Cited in: Klotho

GHK stimulates collagen, elastin, and glycosaminoglycan synthesis while attracting immune cells to wound sites.

Population: In-vitro fibroblast and wound healing models

Cited in: GHK-Cu

KPV enters intestinal cells via the PepT1 transporter to strongly inhibit NF-κB and reduce pro-inflammatory cytokine production.

Population: Human intestinal epithelial cell lines (Caco-2, HT-29)

Cited in: KPV

Semax upregulated expression of BDNF and NGF genes in the hippocampus and frontal cortex of rats.

Population: Wistar rats with focal cerebral ischemia

Cited in: Semax

Melanocortin receptor agonists demonstrated efficacy in both male and female sexual dysfunction through central nervous system pathways.

Population: Review of preclinical and early clinical studies

Cited in: PT-141

MGF peptide addition significantly enhanced satellite cell proliferation compared to controls.

Population: C2C12 murine myoblast cell cultures

Cited in: MGF

VIP effectively restores immune tolerance and reduces joint destruction in models of rheumatoid arthritis and other autoimmune conditions.

Population: Animal models of rheumatoid arthritis and experimental colitis

Cited in: VIP

CJC-1295 with DAC produced sustained elevations in GH and IGF-1 levels lasting up to 2 weeks after a single injection.

Population: Healthy adults aged 21-61 (n=33)

Cited in: CJC-1295 , What Are Peptides? A Beginner's Guide

Semax demonstrated significant nootropic activity including improved memory consolidation and attention in both healthy subjects and stroke patients.

Population: Preclinical models and Russian clinical studies

Cited in: Semax

Intranasal Semax administration significantly increased BDNF protein levels in the rat basal forebrain and hippocampus.

Population: Adult Wistar rats

Cited in: Semax

Antimicrobial peptides including LL-37 serve dual roles as direct pathogen killers and immune system modulators.

Population: Comprehensive review of human antimicrobial peptide biology

Cited in: LL-37

Sermorelin successfully preserves the physiological pulsatility of growth hormone release and prevents the pituitary down-regulation seen with exogenous hGH.

Population: Review of clinical data in adult GH-deficient patients

Cited in: Sermorelin

Established thymosin beta-4 as the primary intracellular actin-sequestering protein critical for cell migration and tissue repair.

Population: In-vitro cell models

Cited in: TB-500

Modified GRF 1-29 produced dose-dependent increases in growth hormone secretion with preserved pulsatile release patterns.

Population: Healthy adult males (n=21)

Cited in: CJC-1295

Identified the specific splicing switch from MGF to systemic IGF-1 following mechanical overload.

Population: Review of rabbit and rodent muscle overload models

Cited in: MGF

Intranasal oxytocin potently reduces amygdala activation and decreases fear-related responses.

Population: Healthy adult males (n=15) with fMRI neuroimaging

Cited in: Oxytocin

Identified MGF as a local tissue repair factor that activates muscle stem cells to provide extra nuclei for muscle hypertrophy.

Population: Review of MGF biology in human and rabbit muscle models

Cited in: PEG-MGF

Showed that MGF administration significantly protected motor neurons from death following ischemic injury.

Population: Rat middle cerebral artery occlusion model

Cited in: PEG-MGF

Selank produced significant anxiolytic effects comparable to benzodiazepines without sedation or motor impairment.

Population: BALB/c mice in elevated plus maze

Cited in: Selank

Epithalon administration increased telomerase activity and extended lifespan by 13% in aging animal models.

Population: Aged rats and human cell cultures

Cited in: Epithalon

VIP selectively downregulates pro-inflammatory cytokines while upregulating anti-inflammatory mediators, acting as a potent macrophage deactivator.

Population: Review of VIP biology in immune and neural tissues

Cited in: VIP

Epithalon treatment restored heterochromatin condensation patterns in aged rats to levels resembling younger animals.

Population: Aged Wistar rats (24 months)

Cited in: Epithalon

LL-37 demonstrates broad-spectrum antimicrobial activity against bacteria, fungi, and enveloped viruses through membrane disruption.

Population: In-vitro microbial culture studies

Cited in: LL-37

Inhaled VIP decreased mean pulmonary artery pressure and significantly improved exercise capacity in patients with severe pulmonary hypertension.

Population: Patients with severe pulmonary arterial hypertension (n=20)

Cited in: VIP

Demonstrated that MGF expression precedes IGF-1Ea and uniquely drives initial stem cell expansion.

Population: C2C12 myoblast stretch-injury models

Cited in: MGF

Demonstrated that MGF distinctly promotes myoblast proliferation, whereas mature IGF-1 promotes differentiation, confirming they operate via different mechanisms.

Population: C2C12 myoblast cell cultures

Cited in: PEG-MGF

AOD-9604 stimulated lipolysis and inhibited lipogenesis in adipose tissue without affecting IGF-1 or insulin levels.

Population: ob/ob mice

Cited in: AOD-9604

Chronic AOD-9604 treatment increased fat oxidation and produced significant weight reduction in obese mice.

Population: ob/ob obese mice

Cited in: AOD-9604

Identified Humanin as a potent survival factor that protects neurons from Alzheimer's-related toxicity.

Population: Primary cortical neurons treated with familial AD gene products

Cited in: Humanin

KPV demonstrated significant antimicrobial and antifungal properties, particularly against Staphylococcus aureus and Candida albicans.

Population: In-vitro microbial cultures (S. aureus, C. albicans)

Cited in: KPV

Chronic ipamorelin treatment significantly increased longitudinal bone growth and body weight gain in rats.

Population: Female rats treated for 15 days

Cited in: Ipamorelin

Systemic administration alters glucose metabolism, aggressively driving nutrients into muscle rather than adipose tissue

Population: Growing rats with continuous IGF-1 LR3 infusion

Cited in: IGF-1 LR3

The peptide demonstrated safety and efficacy in stimulating endogenous GH production, establishing its baseline clinical utility before highly modified analogs existed.

Population: Children with idiopathic GH deficiency in clinical trials

Cited in: Sermorelin

Ipamorelin selectively stimulated growth hormone release without affecting cortisol, prolactin, or ACTH levels in swine.

Population: Pentobarbital-anesthetized swine

Cited in: Ipamorelin

Both Melanotan analogs demonstrated potent melanogenic activity; Melanotan II additionally showed appetite-suppressing and sexual function effects via MC4R.

Population: Review of preclinical and Phase I human studies

Cited in: Melanotan II

Gonadorelin exhibits an extremely rapid clearance rate with a plasma half-life of roughly 2-4 minutes.

Population: Healthy adult male volunteers (n=12)

Cited in: Gonadorelin

Defects in gene expression yielded mice with severe premature aging phenotypes, establishing Klotho's role in lifespan regulation.

Population: Klotho gene knockout mice

Cited in: Klotho

Melanotan II stimulated melanogenesis and produced significant skin darkening without UV exposure in animal models.

Population: Murine melanoma cell models and human skin equivalents

Cited in: Melanotan II

The LR3 modification prevents binding to IGFBPs, dramatically increasing the tissue-building potency compared to native IGF-1

Population: Rat skeletal muscle preparations

Cited in: IGF-1 LR3

GHRH analogs significantly promote non-REM sleep and increase the duration of slow-wave sleep periods in mammalian models.

Population: Human sleep studies and rodent EEG models

Cited in: Sermorelin

GHRP-6 activated phosphatidylinositol signaling pathways in pituitary cells, confirming its mechanism distinct from GHRH.

Population: Rat pituitary cell cultures

Cited in: GHRP-6

Evading binding proteins allows free IGF-1 analogs to maintain continuous receptor activation

Population: In-vitro cell proliferation assays

Cited in: IGF-1 LR3

GHRP-6 produced robust, dose-dependent growth hormone release significantly exceeding GHRH alone in healthy subjects.

Population: Healthy adult volunteers (n=8)

Cited in: GHRP-6

DSIP promoted delta wave sleep onset and duration without suppressing REM sleep or causing morning sedation.

Population: Human sleep studies and animal EEG models

Cited in: DSIP

Characterized DSIP as a stress-protective factor that normalizes disrupted circadian rhythms and modulates endocrine function.

Population: Rabbit brain tissue isolation and rodent models

Cited in: DSIP

Cited in: Biological Roles of Peptides in Humans , Peptide Hormones and Their Functions

Cited in: Biological Roles of Peptides in Humans

Cited in: Biosynthesis of Peptides

Cited in: Biosynthesis of Peptides , Glutathione and Non-Ribosomal Peptides

Cited in: Biosynthesis of Peptides , Prohormone Convertases

Cited in: Chemical Composition of Peptides

Cited in: Chemical Composition of Peptides

Cited in: Comparative Analysis of Peptides and Proteins

Cited in: Comparative Analysis of Peptides and Proteins , Intrinsically Disordered Proteins (IDPs)

Cited in: Degradation Pathways of Peptides

Cited in: Degradation Pathways of Peptides

Cited in: Degradation Pathways of Peptides

Cited in: Peptide Hormones and Their Functions , Bioactive Peptides and Signaling Pathways

Cited in: Peptide Hormones and Their Functions

Cited in: Peptide Synthesis Techniques

Cited in: Peptide Synthesis Techniques

Cited in: Peptide Synthesis Techniques , Native Chemical Ligation (NCL)

Cited in: Peptide and Protein Structure , The Hydrophobic Effect in Protein Folding

Cited in: Peptide and Protein Structure , The Hydrophobic Effect in Protein Folding

Cited in: Peptide and Protein Structure , Peptide Secondary Structures

Cited in: Therapeutic Applications of Peptides

Cited in: Therapeutic Applications of Peptides , How Do Peptides Work in the Body?

Cited in: Therapeutic Applications of Peptides

Cited in: Peptide Post-Translational Modifications

Cited in: Peptide Post-Translational Modifications

Cited in: Peptide Post-Translational Modifications

Cited in: Antimicrobial Peptides and Host Defense

Cited in: Antimicrobial Peptides and Host Defense

Cited in: Antimicrobial Peptides and Host Defense

Cited in: Glutathione and Non-Ribosomal Peptides

Cited in: Glutathione and Non-Ribosomal Peptides

Cited in: Prohormone Convertases

Cited in: Prohormone Convertases

Cited in: Intrinsically Disordered Proteins (IDPs)

Cited in: Intrinsically Disordered Proteins (IDPs)

Cited in: Strategies for Peptide Stabilization

Cited in: Strategies for Peptide Stabilization , Peptidomimetics and Peptide Engineering

Cited in: Strategies for Peptide Stabilization

Cited in: Oral Peptide Delivery Systems

Cited in: Oral Peptide Delivery Systems

Cited in: Oral Peptide Delivery Systems

Cited in: Venom-Derived Peptides in Medicine

Cited in: Venom-Derived Peptides in Medicine

Cited in: Venom-Derived Peptides in Medicine

Cited in: Peptide-Drug Conjugates (PDCs)

Cited in: Peptide-Drug Conjugates (PDCs)

Cited in: Peptide-Drug Conjugates (PDCs)

Cited in: Native Chemical Ligation (NCL)

Cited in: Native Chemical Ligation (NCL)

Cited in: Chaperone-Mediated Protein Folding

Cited in: Chaperone-Mediated Protein Folding

Cited in: Chaperone-Mediated Protein Folding

Cited in: Peptidomics and Mass Spectrometry

Cited in: Peptidomics and Mass Spectrometry

Cited in: Peptidomics and Mass Spectrometry

Cited in: Peptide Secondary Structures

Cited in: Peptide Secondary Structures , Peptidomimetics and Peptide Engineering

Cited in: Bioactive Peptides and Signaling Pathways

Cited in: Bioactive Peptides and Signaling Pathways

Cited in: The Hydrophobic Effect in Protein Folding

Cited in: Recombinant Peptide Production , Recombinant Peptide Production

Cited in: Recombinant Peptide Production

Cited in: Peptidomimetics and Peptide Engineering

Cited in: Green Chemistry in Peptide Synthesis

Cited in: Green Chemistry in Peptide Synthesis

Cited in: Green Chemistry in Peptide Synthesis

Cited in: Amphipathic Helices in Antimicrobial Peptides

Cited in: Amphipathic Helices in Antimicrobial Peptides

Cited in: Amphipathic Helices in Antimicrobial Peptides

Cited in: Cell-Penetrating Peptides (CPPs)

Cited in: Cell-Penetrating Peptides (CPPs)

Cited in: Cell-Penetrating Peptides (CPPs)

Cited in: Insulin Structure and Stability

Cited in: Insulin Structure and Stability

Cited in: Insulin Structure and Stability

Cited in: MHC Peptide Presentation

Cited in: MHC Peptide Presentation

Cited in: MHC Peptide Presentation

Cited in: Neuropeptides vs. Peptide Hormones

Cited in: Neuropeptides vs. Peptide Hormones

Cited in: Neuropeptides vs. Peptide Hormones

Cited in: Peptide Hormones vs. Steroid Hormones

Cited in: Peptide Hormones vs. Steroid Hormones

Cited in: Peptide Hormones vs. Steroid Hormones

Cited in: Cyclic Peptides and Structural Constraints

Cited in: Cyclic Peptides and Structural Constraints

Cited in: Cyclic Peptides and Structural Constraints

Cited in: Peptide Folding and Disulfide Bridges

Cited in: Peptide Folding and Disulfide Bridges

Cited in: Peptide Folding and Disulfide Bridges

Cited in: Are Peptides Legal? Country-by-Country Guide

Cited in: Are Peptides Legal? Country-by-Country Guide

Cited in: Are Peptides Legal? Country-by-Country Guide

Cited in: Are Peptides Legal? Country-by-Country Guide

Cited in: Are Peptides Safe? Risk vs Benefit , Best Peptides for Fat Loss , How to Choose a Peptide , Peptide Cycling: When to Take Breaks , Peptide Side Effects: What You Need to Know , What Are Peptides? A Beginner's Guide

Cited in: Are Peptides Safe? Risk vs Benefit

Cited in: Are Peptides Safe? Risk vs Benefit

Cited in: Are Peptides Safe? Risk vs Benefit

Cited in: Best Peptides for Anti-Aging

Cited in: Best Peptides for Anti-Aging

Cited in: Best Peptides for Anti-Aging

Cited in: Best Peptides for Anti-Aging , Best Peptides for Fat Loss

Cited in: Best Peptides for Anti-Aging

Cited in: Best Peptides for Fat Loss , How to Choose a Peptide , Peptides for Women: What You Need to Know

Cited in: Best Peptides for Fat Loss

Cited in: Best Peptides for Fat Loss

Cited in: Best Peptides for Muscle Growth , Peptides for Women: What You Need to Know , Peptides vs Steroids: How They Compare

Cited in: Best Peptides for Muscle Growth

Cited in: Best Peptides for Muscle Growth , Best Peptides for Muscle Growth

Cited in: Best Peptides for Recovery and Healing

Cited in: Best Peptides for Recovery and Healing

Cited in: Best Peptides for Recovery and Healing

Cited in: Best Peptides for Recovery and Healing , Peptides for Women: What You Need to Know

Cited in: How Do Peptides Work in the Body?

Cited in: How Do Peptides Work in the Body? , Peptide Side Effects: What You Need to Know

Cited in: How Do Peptides Work in the Body?

Cited in: How to Choose a Peptide

Cited in: How to Choose a Peptide

Cited in: How to Reconstitute Peptides: Step-by-Step

Cited in: How to Reconstitute Peptides: Step-by-Step

Cited in: How to Reconstitute Peptides: Step-by-Step

Cited in: Peptide Cycling: When to Take Breaks , Peptide Side Effects: What You Need to Know

Cited in: Peptide Cycling: When to Take Breaks

Cited in: Peptide Side Effects: What You Need to Know

Cited in: Peptide Stacking: Combinations That Work

Cited in: Peptide Stacking: Combinations That Work

Cited in: Peptide Stacking: Combinations That Work

Cited in: Peptide Stacking: Combinations That Work

Cited in: How to Store and Handle Peptides

Cited in: How to Store and Handle Peptides

Cited in: How to Store and Handle Peptides

Cited in: Peptides for Women: What You Need to Know

Cited in: Peptides vs SARMs: Key Differences

Cited in: Peptides vs SARMs: Key Differences

Cited in: Peptides vs SARMs: Key Differences

Cited in: Peptides vs SARMs: Key Differences

Cited in: Peptides vs Steroids: How They Compare

Cited in: Peptides vs Steroids: How They Compare

Cited in: Peptides vs Steroids: How They Compare

Cited in: SubQ vs IM Peptide Injection

Cited in: SubQ vs IM Peptide Injection

Cited in: SubQ vs IM Peptide Injection

Cited in: What Are Peptides? A Beginner's Guide

Cited in: What Are Peptides? A Beginner's Guide